Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Managing Post Inflammatory Hyperpigmentation and Traumatic Tattoos
Description
Dr. Roy Geronimus presents on managing post-inflammatory hyperpigmentation (PIH), traumatic tattoos, and xanthelasma. He emphasizes the importance of ultraviolet (UV) protection and the benefits of topical tranexamic acid. He recommends low-energy, low-density non-ablative fractional lasers, such as the 1927 nm thulium and diode lasers, over traditional treatments like the Fraxel laser, which he believes can worsen PIH. The presentation showcases his success in treating PIH with these advanced lasers, discussing various case studies illustrating improvements. Geronimus also addresses traumatic tattoos, which can be caused by substances like asphalt and explosives. He notes the need for effective pain management during laser treatments for these cases and shares successful treatment examples using pico- and Q-switched lasers. Finally, he covers xanthelasma removal, advocating for laser treatment over surgery due to the recurrence of lesions and potential complications from surgery. Dr. Geronimus concludes that using ablative lasers effectively and selectively can lead to excellent results with minimal scarring.
View moreConclusions
- Post inflammatory hyperpigmentation (PIH) can be effectively managed with low energy, low density, non-ablative fractional lasers, such as 1927 nm thulium lasers.
- Oral tranexamic acid can enhance the treatment of PIH but is not always required.
- Higher energy lasers, like the Fraxel, are not suitable for treating PIH or melasma and may worsen the condition.
- Traumatic tattoos can be treated effectively with picosecond or Q-switched lasers, utilizing different wavelengths based on the color of the foreign body.
- Effective pain management is necessary during the treatment of traumatic tattoos, sometimes requiring IV sedation.
- Xanthelasma is better treated with laser approaches rather than surgical excision due to potential for recurrence and complications.
- Partial ablation of xanthelasma can lead to effective results, allowing the body's inflammatory response to clear the remaining lesion without extensive damage.
- Gary Monheit, MD, FAAD
- Rhoda Narins, MD, FAAD
- Vince Bertucci, MD, FAAD
- Roy G. Geronemus, MD, FAAD
- Kavita Mariwalla, MD, FAAD
- Girish S. Munavalli, MD, MHS, FAAD
- Jill S. Waibel, MD, FAAD
- Omar Ibrahimi, MD, PhD, FAAD
- Sabrina G. Fabi, MD, FAAD
- Roy G. Geronemus, M.D., Clinical Professor of Dermatology, New York University Medical Center